EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility of a Pilot Crowdsourced Syndromic and Virological Surveillance Platform for Respiratory Illness in South Africa, CoughWatchSA, 2022

Mvuyo Makhasi, Jocelyn Moyes, Daniela Paolotti, Mignon du Plessis, Fahima Moosa, Nicole Wolter, Phiwokuhle Ntombela, Siyabonga Mazibuko, Noluthando Duma, Jackie Kleynhans, Anne von Gottberg, Stefano Tempia und 2 weitere

Influenza and Other Respiratory Viruses · 2026

DOI: 10.1111/irv.70225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2026. Verfasst von Mvuyo Makhasi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, J…. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Respiratory Tract Infections, Epidemiological Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Digital participatory surveillance (DPS) may provide information on reported influenza‐like illnesses (ILI). Combining DPS with laboratory testing allows pathogen identification. We assessed the feasibility of DPS and home‐based self‐swabbing (HBSS) in South Africa.

Methods

We enrolled a cohort of individuals aged ≥ 18 years who completed weekly respiratory symptoms questionnaires from March to October 2022. We calculated the weekly percentage of reported ILI and COVID‐19 and compared it with weekly private sector respiratory consultations (WPSRC). Symptomatic participants were offered HBSS for influenza and SARS‐CoV‐2 detection by polymerase chain reaction (PCR). We assessed six feasibility indicators.

Results

Recruitment capability: Twenty‐six percent (249/954) of participants accessed the platform and enrolled, and 92% (81/88) of participants eligible for HBSS were enrolled. Acceptability: Fifteen percent (32/249) completed the acceptability questionnaire with 100% (32/32) willing to participate in future studies, and 16% (39/249) withdrew from the study. Representativeness: Fifty percent (125/249) were aged 18–39 years, predominantly female 71%, and 79% had a tertiary qualification. Reliability: Thirty‐eight percent (80/210) were active participants, median weekly active participation of 23% (interquartile range [IQR]: 19%–29%). Accuracy: Two percent (31/1440) and 25% (359/1440) of reports met ILI and COVID‐19, respectively. Influenza and SARS‐CoV‐2 were detected in 7% (6/81) and 32% (26/81) of tested samples, respectively. There was low correlation with WPSRC (0.08, 95% CI, 0.27–0.43) for ILI and (0.36, 95% CI, 0.11–0.62) for COVID19. Usefulness: Symptoms were reported in 32% (459/1440) of reports, and 11% (49/459) sought medical care.

Conclusion

The study was feasible; however, low enrolment numbers limit power. Linkage to HBSS was successful and demonstrates the potential for pathogen confirmation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Influenza, HumanRespiratory Tract InfectionsEpidemiological MonitoringHumansSouth AfricaFemaleAdultMaleFeasibility StudiesMiddle AgedPilot ProjectsYoung AdultSARS-CoV-2AdolescentSurveys and QuestionnairesAged

Stichwörter der Autor:innen

COVID19CoughWatchSADPSILIfeasibilityparticipatory surveillanceself‐swabbing

Autor:innen und Institutionen

  • Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.
  • School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
  • Institute for Scientific Interchange Foundation, Turin, Italy.
  • School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

ORCID-Profile: Cheryl Cohen

Förderung

  • Sanofi

Zitieren

APA

Makhasi, M., Moyes, J., Paolotti, D., du Plessis, M., Moosa, F., Wolter, N., Ntombela, P., Mazibuko, S., Duma, N., Kleynhans, J., von Gottberg, A., Tempia, S., Walaza, S., & Cohen, C. (2026). Feasibility of a Pilot Crowdsourced Syndromic and Virological Surveillance Platform for Respiratory Illness in South Africa, CoughWatchSA, 2022. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70225

Vancouver

Makhasi M, Moyes J, Paolotti D, du Plessis M, Moosa F, Wolter N, et al. Feasibility of a Pilot Crowdsourced Syndromic and Virological Surveillance Platform for Respiratory Illness in South Africa, CoughWatchSA, 2022. Influenza and Other Respiratory Viruses. 2026. doi:10.1111/irv.70225

BibTeX
@article{Makhasi2026,
  author = {Makhasi, Mvuyo and Moyes, Jocelyn and Paolotti, Daniela and du Plessis, Mignon and Moosa, Fahima and Wolter, Nicole and Ntombela, Phiwokuhle and Mazibuko, Siyabonga and Duma, Noluthando and Kleynhans, Jackie and von Gottberg, Anne and Tempia, Stefano and Walaza, Sibongile and Cohen, Cheryl},
  title = {Feasibility of a Pilot Crowdsourced Syndromic and Virological Surveillance Platform for Respiratory Illness in South Africa, CoughWatchSA, 2022},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2026},
  doi = {10.1111/irv.70225}
}
Kostenlos starten →